PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
![PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358](https://images.unsplash.com/photo-1535320903710-d993d3d77d29?auto=format&fit=crop&w=1600&q=70)
IDAHO FALLS, Idaho, May 29, 2026 /PRNewswire/ -- PharmaLogic Holdings Corp., ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announced an expansion of its manufacturing partnership with Ratio...
IDAHO FALLS, Idaho, May 29, 2026 /PRNewswire/ -- PharmaLogic Holdings Corp., ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announced an expansion of its manufacturing partnership with Ratio...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.